Hiroyuki Konaka

2.0k citations
81 papers · 1.4k indexed · h-index 22

Hiroyuki Konaka

80 papers receiving 1.4k citations

Peers

Hiroyuki Konaka
Comparison fields: 5 of 114
  • Urology 151
  • Endocrinology, Diabetes and Metabolism 354
  • Pulmonary and Respiratory Medicine 447
  • Oncology 305
  • Cancer Research 157
Replace Mark Feneley with:
Mark Feneley United Kingdom
Soum D. Lokeshwar United States
Xiaming Liu China
Al B. Barqawi United States
P D Abel United Kingdom
Jakub Dobruch Poland
Christoph Zenzmaier Austria
Yuehua Huang China
Long Wang China
Matthew Simms United Kingdom
Hiroyuki Konaka relative to Mark Feneley United Kingdom Mark Feneley's profile →
Citations per field
00.5×2.9×
Mark Feneley · 1×
Citations per year

Countries citing papers authored by Hiroyuki Konaka

Since Specialization
Citations

This map shows the geographic impact of Hiroyuki Konaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroyuki Konaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroyuki Konaka more than expected).

Fields of papers citing papers by Hiroyuki Konaka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroyuki Konaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroyuki Konaka. The network helps show where Hiroyuki Konaka may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Hiroyuki Konaka, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hiroyuki Konaka Line = papers co-authored together Hiroyuki Konaka links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20241
2 20231
3 20231
4 20221
5 20193
6 201712
7 20170
8 201726
9 20169
10 201617
11 20144
12 20142
13 201310
14 201114
15 201113
16 20106
17 20093
18 20066
19 20017
20 19983

About Hiroyuki Konaka

Hiroyuki Konaka is a scholar working on Urology, Endocrinology, Diabetes and Metabolism and Pulmonary and Respiratory Medicine, having authored 81 papers that have together received 1.4k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (25 papers), Hormonal and reproductive studies (19 papers), Prostate Cancer Diagnosis and Treatment (16 papers), Bladder and Urothelial Cancer Treatments (13 papers), Pharmacology and Obesity Treatment (9 papers), Renal cell carcinoma treatment (7 papers), Sexual function and dysfunction studies (7 papers) and Renal and related cancers (6 papers). The work is most often cited by research in Urology (151 citations), Endocrinology, Diabetes and Metabolism (354 citations) and Pulmonary and Respiratory Medicine (447 citations). Hiroyuki Konaka has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Mikio Namiki, Atsushi Mizokami, Yoshifumi Kadono, Eitetsu Koh, Kouji Izumi, Kazuyoshi Shigehara, Yasuhide Kitagawa, Yasuhide Kitagawa, Kazuhiro Sugimoto and Haiyen E. Zhau. Their work appears in journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026